Chapter 6 - Immunotherapy: Agents and Targets

Virginia R. Bayer
Renee Spinks

Chapter 6 addresses a variety of approved immunotherapies, including their molecular targets, FDA-approved indications, and management of adverse events.

Price: $12.95